Amring Pharmaceuticals Inc
General
Total Cases1
Active Cases--
Patents9
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 06/29/23 | SUMMONS ISSUED as to RUBICON RESEARCH PRIVATE LTD.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jd, ) (Entered: 06/29/2023) | |
| 06/29/23 | AO120 Patent/Trademark Form filed. (Attachments: # 1 Complaint, # 2 Civil Cover Sheet, # 3 Exhibit A, # 4 Exhibit B, # 5 Exhibit C, # 6 Exhibit D, # 7 Exhibit E, # 8 Exhibit F, # 9 Exhibit G, # 10 Exhibit H) (jd, ) (Entered: 06/29/2023) | |
| 06/29/23 | Case Assigned to Magistrate Judge James B. Clark. (ak, ) (Entered: 06/29/2023) | |
| 06/29/23 | Case Assigned to Magistrate Judge James B. Clark. (ak, ) (Entered: 06/29/2023) | |
| 06/28/23 | Corporate Disclosure Statement by AMRING PHARMACEUTICALS INC identifying Nordic Group B.V. as Corporate Parent.. (PANZER, DOUGLAS) (Entered: 06/28/2023) | |
| 06/28/23 | COMPLAINT against RUBICON RESEARCH PRIVATE LIMITED ( Filing and Admin fee $ 402 receipt number ANJDC-14420553) with JURY DEMAND, filed by AMRING PHARMACEUTICALS INC. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit US Patent No 7947739, # 3 Exhibit US Patent No 8022106, # 4 Exhibit US Patent No 8273795, # 5 Exhibit US Patent No 8487005, # 6 Exhibit US Patent No 8791160, # 7 Exhibit US Patent No 8809394, # 8 Exhibit US Patent No 8957113, # 9 Exhibit US Patent No 9060939)(PANZER, DOUGLAS) (Entered: 06/28/2023) |